Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780481 · ClinicalTrials.gov registry record · NA
Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00780481 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 13 participants.
The verdict
NCT00780481, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
T-PA release is impaired in obese subjects. In order to have a better mechanistic understanding of t-PA release, we will compare t-PA release to Flow Mediated Vasodilation, Radial Artery Tonometry, and other markers of endothelial function and oxidative stress.
Interventions
- DRUG Bradykinin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780481
The ClinicalTrials.gov registry entry for NCT00780481 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bradykinin is the first listed.
NCT00780481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00780481 about?
NCT00780481 is a clinical study titled "Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation". T-PA release is impaired in obese subjects. In order to have a better mechanistic understanding of t-PA release, we will compare t-PA release to Flow Mediated Vasodilation, Radial Artery Tonometry, and other markers of endothelial function and oxidative stress.
What is the current status of trial NCT00780481?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2007-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00780481?
The interventions under investigation include: Bradykinin (DRUG).
Who is sponsoring clinical trial NCT00780481?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.